Clinical Challenges: Myeloma and Concomitant type 2 Diabetes
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2013-01-01
|
| Series: | International Journal of Hematology-Oncology and Stem Cell Research |
| Subjects: | |
| Online Access: | http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/353/453 |
| _version_ | 1797762385890508800 |
|---|---|
| author | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb |
| author_facet | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb |
| author_sort | Yasar Albushra Abdul Rahiem Ahmed |
| collection | DOAJ |
| description | Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. |
| first_indexed | 2024-03-12T19:27:32Z |
| format | Article |
| id | doaj.art-49c49dca287a4a4aa623d3669d7978d6 |
| institution | Directory Open Access Journal |
| issn | 2008-3009 2008-2207 |
| language | English |
| last_indexed | 2024-03-12T19:27:32Z |
| publishDate | 2013-01-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | International Journal of Hematology-Oncology and Stem Cell Research |
| spelling | doaj.art-49c49dca287a4a4aa623d3669d7978d62023-08-02T04:49:11ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072013-01-01713138Clinical Challenges: Myeloma and Concomitant type 2 DiabetesYasar Albushra Abdul Rahiem AhmedAwad EltayebMultiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/353/453Multiple MyelomaDiabetes Mellitus |
| spellingShingle | Yasar Albushra Abdul Rahiem Ahmed Awad Eltayeb Clinical Challenges: Myeloma and Concomitant type 2 Diabetes International Journal of Hematology-Oncology and Stem Cell Research Multiple Myeloma Diabetes Mellitus |
| title | Clinical Challenges: Myeloma and Concomitant type 2 Diabetes |
| title_full | Clinical Challenges: Myeloma and Concomitant type 2 Diabetes |
| title_fullStr | Clinical Challenges: Myeloma and Concomitant type 2 Diabetes |
| title_full_unstemmed | Clinical Challenges: Myeloma and Concomitant type 2 Diabetes |
| title_short | Clinical Challenges: Myeloma and Concomitant type 2 Diabetes |
| title_sort | clinical challenges myeloma and concomitant type 2 diabetes |
| topic | Multiple Myeloma Diabetes Mellitus |
| url | http://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/353/453 |
| work_keys_str_mv | AT yasaralbushraabdulrahiemahmed clinicalchallengesmyelomaandconcomitanttype2diabetes AT awadeltayeb clinicalchallengesmyelomaandconcomitanttype2diabetes |